We are the Peptide Experts
JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.
Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.
JPT’s peptides continue to contribute to important SARS-CoV-2 publications
Our expertise is directed at the research and development of specific peptides for immunotherapies, vaccines and the accompanying immune monitoring, which has resulted in a variety of COVID-19 specific products. We proudly present some recent high-impact publications describing the use of these peptide products for fighting COVID-19. Have a look!
NEW: Delta & Kappa SARS-CoV-2 PepMixes™
Identify Epitope Resolved Antibody Responses with SARS-CoV-2 Peptide Microarrays
In a recent publication using JPT’s RepliTope™ Antigen Collection Pan-Coronavirus peptide microarrays which display the whole SARS-CoV-2 proteome as well as relevant common cold corona virus antigens, a widespread cross-reactivity was detected across immunodominant antigen regions. Importantly, a statistically significant discrimination between COVID-19 patients and controls could be achieved allowing selection of dedicated peptides for further development.